Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4564563015 | Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4564564014 | Atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5278541000052110 | atropinsulfat 25 mikrog och difenoxin (som difenoxinhydroklorid) 1 mg, oral tablett | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Atropine sulfate | true | Inferred relationship | Some | 1 | |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Difenoxin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Atropine sulfate | true | Inferred relationship | Some | 1 | |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Atropine and difenoxin only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Difenoxin hydrochloride (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely atropine sulfate 25 microgram and difenoxin (as difenoxin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR